相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD
Mary P. Moore et al.
HEPATOLOGY (2022)
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis
Xiaobo Wang et al.
JOURNAL OF HEPATOLOGY (2022)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
Kenneth Cusi et al.
ENDOCRINE PRACTICE (2022)
Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice
Simon T. Hui et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2021)
Mechanisms of Fibrosis Development in NASH
Robert F. Schwabe et al.
GASTROENTEROLOGY (2020)
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2020)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice
Xiaobo Wang et al.
HEPATOLOGY COMMUNICATIONS (2019)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data
Mohammad Nasser Kabbany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Recent progress in development of siRNA delivery vehicles for cancer therapy
Hyun Jin Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
The Role of Cholesterol in the Pathogenesis of NASH
George N. Ioannou
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis
Madlen Matz-Soja et al.
ELIFE (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Francisco Caballero et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
分享论文
